Diasorin | DIA - Cost Of Sales

Stock Price
73.48
Daily Change
-1.10 -1.47%
Monthly
2.37%
Yearly
-26.78%
Q1 Forecast
70.01

Diasorin reported EUR99.64M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Amplifon EUR 460.17M 14.78M Sep/2025
Avanos Medical USD 91.8M 8.9M Sep/2025
Brookdale Senior Living USD 602.31M 42.07M Sep/2025
Cencora USD 80.77B 3.02B Sep/2025
Diasorin EUR 99.64M 4.71M Sep/2025
Encompass Health USD 150.9M 3.9M Dec/2025
Enovis USD 263.69M 18.96M Sep/2025
GE HealthCare Technologies USD 3.15B 131M Sep/2025
OPKO Health USD 104.78M 32.97M Sep/2025
Zimmer Biomet Holdings USD 735.8M 17M Sep/2025